ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1 - Chen, Yunhao; Zhao, Yanchun; Chen, Junru; Peng, Chuanhui; Zhang, Yanpeng; Tong, Rongliang; Cheng, Qiyang; Yang, Beng; Feng, Xiaode; Lu, Yuejie; Xie, Haiyang; Zhou, Lin; et al. (Molecular cancer, 2020)
Keywords: ALKBH5; Antibodies; Cell proliferation; Demethylation; DNA methylation; Epigenetic inheritance; Epigenetics; Gene expression; Hepatocellular carcinoma; Hepatocellular carcinoma (HCC); Immunoprecipitation; Liver cancer; LYPD1; Malignancy; Medical prognosis; Medical research; Methyltransferases; N6-methyladenosine; N6-methyladenosine (m6A); Pathogenesis; Post-transcription; Proteins; Ribonucleic acid; RNA; RNA sequencing; Software; Statistical analysis; Tumor suppressor genes; Tumorigenesis; Tumorigenicity; Tumors; United States--US; China; Germany